Crossmark

Epicardial adipose tissue thickness in systemic sclerosis patients without overt cardiac disease

Crossref DOI link: https://doi.org/10.1007/s00296-019-04306-8

Published Online: 2019-04-25

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Temiz Karadag, Duygu https://orcid.org/0000-0002-5891-2032
Sahin, Tayfun https://orcid.org/0000-0002-0851-2946
Tekeoglu, Senem https://orcid.org/0000-0001-5539-8755
Ozdemir Isik, Ozlem https://orcid.org/0000-0002-2985-3723
Yazici, Ayten https://orcid.org/0000-0003-2167-4509
Cefle, Ayse https://orcid.org/0000-0002-3273-7969
License Information

Text and Data Mining valid from 2019-04-25
More Information

Article History

Received: 28 January 2019

Accepted: 15 April 2019

First Online: 25 April 2019

Compliance with ethical standards

:

: None of the authors has financial or non-financial conflicts of interest to disclose.

: This article does not contain any studies with animals performed by any of the authors. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by Kocaeli University School of Medicine Ethics Committee for noninvasive clinical trials with protocol number 178 in 16th June 2015 (KOU KAEK 2015/178). The data of this study were derived during a previous study entitled “Evaluation of the ventricular dysfunction by two-dimensional speckle tracking echocardiography in SSc patients without pulmonary hypertension”.

: Informed consent was obtained from all individual participants included in the study.